While Depression impacts millions of people across the globe, young adults bear a significant portion of that burden; census data collected in 2021 suggests that around 48% of young adults
Efficacy and Safety of Intranasal Esketamine (Spravato) for Depression: An Update
Research on the efficacy and safety of intranasal esketamine (Spravato) as a treatment for Depression continues. In particular, three recent analyses provide additional background for patients interested in learning more
Akathisia from Antidepressants
Finding the right treatment plan to combat major depressive disorder (MDD) is a complicated and delicate endeavor. While some antidepressants may work to help alleviate the daily burdens of Depression,
Do SSRIS affect fertility? The effect of SSRIs on Semen quality
When it comes to comprehensive treatment plans for mood disorders such as Depression and anxiety, selective serotonin reuptake inhibitors (SSRIs) have long been considered a frontline treatment strategy. While antidepressants
Esketamine (Spravato) Treatment as Part of a Depression Relapse Prevention Plan
Although millions of people are empowered to coexist with their Depression through comprehensive and personalized treatment plans, the long-term management of this condition can often be complicated by the potential
Paradoxical Effect of Antidepressants: Can These Medications Sometimes Do More Harm Than Good?
Over the years, countless patients have turned to antidepressants as a definitive answer to their complex psychological challenges such as major depressive disorder (MDD), clinical anxiety, and panic disorder. As
Antidepressant Induced Mania
For decades, antidepressants such as SSRIs have long been regarded as first-line treatment for major depressive disorder (MDD) and other mood disorders; their importance across many different demographics continues to
Pharmacogenetic Testing for Depression: An Update
Selecting effective antidepressants for the treatment Major Depressive Disorder (MDD) is an imprecise practice, with remission rates of just about 30% at the initial treatment choice. The potential of pharmacogenetic
A Study of Single-Dose Psilocybin Treatment for Major Depressive Disorder
Psilocybin Treatment for Major Depressive Disorder (MDD) is a topic of interest for some of the many people struggling with debilitating symptoms of Depression. While not currently approved for the
A New Antidepressant: Discussing Patients’ Auvelity Experience
Whenever a new antidepressant becomes available, patients will want to know what it is like to take it. For this reason, we bring you this discussion of the Auvelity experience